Published in Pharmacol Ther on January 01, 1995
Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother (1998) 4.93
Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol (2001) 2.87
Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth. Chem Biol (2007) 1.82
Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections. J Biol Chem (2009) 1.60
Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother (2010) 1.45
Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Curr Top Med Chem (2011) 1.27
Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob Agents Chemother (1997) 1.23
In vitro and in vivo effects of 14alpha-demethylase (ERG11) depletion in Candida glabrata. Antimicrob Agents Chemother (2001) 1.13
Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc Natl Acad Sci U S A (2000) 1.12
Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother (2005) 1.02
Genetic analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae. Antimicrob Agents Chemother (1999) 1.01
Role of cytochrome P450 in drug interactions. Nutr Metab (Lond) (2008) 0.97
In vitro and in vivo activities of the novel azole antifungal agent r126638. Antimicrob Agents Chemother (2004) 0.94
Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comp Hepatol (2005) 0.88
Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase. BMC Microbiol (2014) 0.77
The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner. PLoS One (2013) 0.76
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity. Front Microbiol (2017) 0.75
Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro. Eur J Clin Pharmacol (2004) 0.75
Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species. Clin Microbiol Rev (2017) 0.75
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics (1996) 6.12
Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother (1998) 4.93
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19
Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32
Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals. Biochem Soc Trans (1990) 2.22
Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol (1990) 2.19
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J Mol Biol (1996) 1.65
Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Nat Struct Biol (1995) 1.53
Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses (1989) 1.38
Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes. Mycoses (1991) 0.99
R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis. Biochem Pharmacol (1990) 0.96
Cytochromes P450 in fungi. Mycoses (1998) 0.91
Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem Biophys Res Commun (1993) 0.86
Cytochrome P450 database. SAR QSAR Environ Res (2001) 0.81
Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. Skin Pharmacol (1988) 0.81
Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity. Protein Sci (1995) 0.81
The sequence homologies of cytochromes P-450 and active-site geometries. J Comput Aided Mol Des (1992) 0.80
Classification and identification of proteins by means of common and specific amino acid n-tuples in unaligned sequences. Comput Methods Programs Biomed (1998) 0.78
Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D. Drug Metab Rev (1994) 0.78
A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase). J Steroid Biochem Mol Biol (1995) 0.77
Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis. Biochem Pharmacol (1992) 0.76
Aromatase inhibitors--mechanisms for non-steroidal inhibitors. Breast Cancer Res Treat (1994) 0.76
On conformation analysis, molecular graphics, fentanyl and its derivatives. Prog Drug Res (1986) 0.75
Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates. Chem Res Toxicol (1997) 0.75
A comparison between the conformation of dexclamol and the tricyclic and butyrophenone type dopamine antagonists. Life Sci (1978) 0.75
From 14 alpha-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells. Biochem Soc Trans (1990) 0.75
A comparison between the solid state conformation of phenmetrazine and the alpha-sympathomimetic pharmacophore pattern. J Pharm Pharmacol (1975) 0.75
Molecular determinants of fungal dimorphism. J Med Vet Mycol (1992) 0.75